Term
Levodopa or levodopa with carbidopa
(therapuetic) |
|
Definition
|
|
Term
LEVODOPA OR LEVODOPA W/ CARBIDOPA
(PHARMALOGICAL CLASS) |
|
Definition
DOPAMINE PRECURSOR--DOPAMINERGIC DRUG
|
|
|
Term
LEVODOPA OR LEVODOPA W/ CARBIDOPA
CONTRAINDICATIONS |
|
Definition
TREATMENT OF NARROW ANGLED GLAUCOMA
AVOID IN CASES OF PSYCHOSES
|
|
|
Term
LEVODOPA OR LEVODOPA W/ CARBIDOPA
ACTION AND USES |
|
Definition
| RESTORES DOPAMINE IN EXTRAPYRAMIDAL AREAS OF BRAIN (UP TO 6 MONTHS) FOR MAX EFFECT |
|
|
Term
LEVODOPA OR LEVODOPA W/ CARBIDOPA
ADMIN ALRERTS |
|
Definition
| ADMINISTER EXACTLY AS ORDERED, DONT WITHDRAWAL ABRUPTLY |
|
|
Term
LEVODOPA OR LEVODOPA W/ CARBIDOPA
ADVERSE EFFECT |
|
Definition
| FATIGUE, DYSTONIA, DYSKIESIA, SLEEP DYSFUNCTION, VOMITING, CONSTIPATION, ORTHOSTATIC HYPOTENSION |
|
|
Term
LEVODOPA OR LEVODOPA W/ CARBIDOPA
INTERACTIONS |
|
Definition
|
|
Term
LEVODOPA OR LEVODOPA W/ CARBIDOPA
OVERDOSE |
|
Definition
| GASTRIC LAVAGE, AIRWAY MANAGEMENT, IV FLUIDS, ADMIN JUDICIOUSLY |
|
|
Term
ATYPICAL ANTIPSYCHOTIC
PROTOTYPE |
|
Definition
|
|
Term
ATYPICAL ANTIPSYCHOTIC
THERAPUETIC CLASS |
|
Definition
| ATYPICAL ANTIPSYCHOTIC, SCHIZOPHRENIA DRUG |
|
|
Term
ATYPICAL ANTIPSYCHOTIC
PHARMACOLOGIC CLASS |
|
Definition
D2 DOPAMINE RECEPTOR ANTAGONIST
SEROTONIN RECEPTOR ANTAGONIST |
|
|
Term
ATYPICAL ANTIPSYCHOTIC
CONTRAINDICATIONS |
|
Definition
OLDER ADULTS WITH DEMENTIA
RELATED PSYCHOSIS--> RISK FOR HF, PNEUMONIA, SUDDEN DEATH
CARDIOVASCULAR DISEASE PRONE TO DYSRYTHMIAS AND HYPOTENSION
PATIENTS WITH HISTORY OF SEIZURES, SUICIDAL THOUGHTS, KIDNEY/LIVER DISEASE |
|
|
Term
ATYPICAL ANTIPSYCHOTIC
ACTIONS/USES |
|
Definition
TREATS IRRATABLITY IN AUTISTIC CHILDREN.
REDUCTION OF EXCITMENT, PARANOIA, NEG. BEHAVIOR |
|
|
Term
ATYPICAL ANTIPSYCHOTIC
ADMIN ALERTS |
|
Definition
SEVERAL WEEKS REQUIRED FOR THERAP. EFFECT
DISCONTINUE MEDICATIONS TO AVOID OVERLAP |
|
|
Term
ATYPICAL ANTIPSYCHOTIC
INTERACTIONS |
|
Definition
| KAVA, VALERIAN, CHAMOMILE--> MAY INCREASE RISPERIDONES CNS DEPRESSANT EFFECT |
|
|
Term
ATYPICAL ANTIPSYCHOTIC
ADVERSE EFFECT |
|
Definition
INVOLUNTARY SHAKING OF: HEAD,NECK, AND ARMS
EPS, HYPERACTIVITY, FATIGUE, NAUSEA, FEVER, ORTHOSTATIC HYPOTENSION
MAY CAUSE WEIGHT GAIN AND HYPERGLYCEMIA-->WORSENING GLUCOSE CONTROL IN DIABETIC PATIENTS
|
|
|
Term
ATYPICAL ANTIPSYCHOTIC
OVERDOSE |
|
Definition
ACTIVATED CHARCOAL, WHICH MAY BE USE WITH SORBITOL
|
|
|
Term
CONVENTIONAL ANTIPSYCHOTIC
PROTOTYPE |
|
Definition
|
|
Term
CONVENTIONAL ANTIPSYCHOTIC
THERAPUETIC CLASS |
|
Definition
| CONVENTIONAL ANTIPSYCHOTIC, SCHIZOPHRENIC DRUG |
|
|
Term
CONVENTIONAL ANTIPSYCHOTIC
PHARMALOGIC |
|
Definition
| D2 DOPAMINE RECEPTOR ANTAGONIST, NONPHENOTHIAZINE |
|
|
Term
CONVENTIONAL ANTIPSYCHOTIC
CONTRAINDICATIONS |
|
Definition
PAKINSON'S DISEASE
SEIZURE DISORDERS
ALCOHOLISM
SEVERE MENTAL DEPRESSION |
|
|
Term
CONVENTIONAL ANTIPSYCHOTIC
ACTIONS/USES |
|
Definition
ACUTE/CHRONIS PSYCHOTIC DISORDERS
TOURETTE'S SYNDROME, UNPROVOKED AGGRESSIVENESS, EXPLOSIVE HYPERACTIVITY |
|
|
Term
CONVENTIONAL ANTIPSYCHOTIC
ADMIN ALERTS |
|
Definition
DO NOT STOP ABRUPTLY
MUST TAKE ALL MEDS AS ORDERED
IF PT DOES NOT COMPLY WITH ORAL--INJECTIONS SHOULD BE CONSIDERED |
|
|
Term
CONVENTIONAL ANTIPSYCHOTIC
INTERACTIONS |
|
Definition
|
|
Term
CONVENTIONAL ANTIPSYCHOTIC
OVERDOSE/ANTIDOTE |
|
Definition
WITH EPS, ANTIPARKINSONISM MEDS SHOULD BE ADMINISTERED
HYPOTENSION SHOULD BE COUNTERED WITH IV FLUIDS, PLASMA, OR CONCENTRATED ALBUMIN OR VASOPRESSOR DRUGS |
|
|
Term
CONVENTIONAL ANTIPSYCHOTIC
ADVERSE EFFECTS |
|
Definition
| PSEUDOPARKINSONISM, AKATHASIA, ACUTE DYSTONIA, EPS, TARDIVE DYSKINESIA |
|
|
Term
PARASYMPATHOMIMETIC
PROTOTYPE |
|
Definition
|
|
Term
PARASYMPATHOMIMETIC
PHARMALOGIC |
|
Definition
| MUSCARINE CHOLINERGEIC RECEPTOR AGONIST |
|
|
Term
PARASYMPATHOMIMETIC
THERAPUETIC |
|
Definition
| NONOBSTRUCTIVE URINARY RETENTION AGENT |
|
|
Term
PARASYMPATHOMIMETIC
STIMULATES |
|
Definition
|
|
Term
PARASYMPATHOMIMETIC
CONTRAINDICATIONS |
|
Definition
PATIENTS WITH ASTHMA, EPILEPSY, OR PARKINSONISM
PATIENTS WITH COPD |
|
|
Term
PARASYMPATHOMIMETIC
INTERACTIONS |
|
Definition
| ANGELS TRUMPET, JIMSON WEED, SCOPALIA |
|
|
Term
PARASYMPATHOMIMETIC
THERAPUETIC EFFECTS |
|
Definition
GLAUCOMA
URINARY RETENTION
MYASTHENIA GRAVIS
ALZHEIRMERS DISEASE |
|
|
Term
PARASYMPATHOMIMETIC
ACTIONS/USES |
|
Definition
STIMULATES SMOOTH-MUSCLE CONTRACTIONS IN IN THE DIGESTIVE/URINARY TRACTS
INCREASE SMOOTH-MUSCLE TONE AND MUSCULAR CONTRACTIONS IN THE GI TRACT FOLLOWING GENERAL ANESTHESIA |
|
|
Term
PARASYMPATHOMIMETIC
OVERDOSE |
|
Definition
ATROPINE SULFEDE-SUBCUTANEOUS INJECTION PREFERRED
IV ROUTE ADMINISTERED IN EMERGENCIES |
|
|
Term
ANTICHOLINERGIC THERAPY
PROTOTYPE |
|
Definition
|
|
Term
ANTICHOLINERGIC THERAPY
PROTOTYPE: ATROPINE
THERAPUTIC CLASS |
|
Definition
| ANTIDOTE FOR AchE POISIONING |
|
|
Term
ANTICHOLINERGIC THERAPY
PROTOTYPE: ATROPINE
PHARMALOGIC CLASS |
|
Definition
| MUSCARINE CHOLINERGIC RECEPTOR ANTAGONIST |
|
|
Term
ANTICHOLINERGIC THERAPY
PROTOTYPE: ATROPINE
THERAPUETIC EFFECTS |
|
Definition
NAUSEA
URINARY RETENTION
OVERACTION
PARKINSON'S DISEASE |
|
|
Term
ANTICHOLINERGIC THERAPY
PROTOTYPE: ATROPINE
ACTION/USES |
|
Definition
INDUCES FIGHT OR FLIGHT
TREAT HYPERMOTILITY DIESEASE OF GI TRACT (IBS)
TREATMENT OF REFLEXIVE BRADYCARDIA IN INFANTS AND INFATILE HYPERTONIS PYLORIC STENOSIS |
|
|
Term
ANTICHOLINERGIC THERAPY
PROTOTYPE: ATROPINE
ADMIN ALERTS |
|
Definition
NEVER ADMINISTER IM
ORAL/SUBCUTANEOUS ARE NOT INTERCHANGABLE |
|
|
Term
ANTICHOLINERGIC THERAPY
PROTOTYPE: ATROPINE
INTERACTIONS |
|
Definition
| ALOE, SERONA REPENS(SAW PALMETTO), BUCKTHORN, CASCARA SAGRADA--> MAY INCREASE ATROPIES EFFECT |
|
|
Term
ANTICHOLINERGIC THERAPY
PROTOTYPE: ATROPINE
ADVERSE EFFECTS |
|
Definition
OBSTRUCTIVE DISORDERS OF GI TRACT
PARALYTIC ILEUS
BLADDER NECK OBSTRUCTION
BPH
CARDIA INSUFFICIENY
ACTUE HEMMORRAGE |
|
|
Term
ANTICHOLINERGIC THERAPY
PROTOTYPE: ATROPINE
OVERDOSE/ANTIDOTE |
|
Definition
SHORT ACTING BARBITURATE OR DISZEPAM(VALIUM) TO CONTROL CONVULSIONS
PHYSOSTIGMIRE- ANTIDOTE FOR ATROPINE POISIONING THAT QUICKLY REVERSES THE COMA CAUSED BY LARGE DOSES OF ATROPINE |
|
|
Term
ANTICHOLINERGIC THERAPY
PROTOTYPE: ATROPINE
EFFECTS ON EYES |
|
Definition
CYCLOPLEGIA DURING EYE EXAMS
MYDRIASIS AND PHOTOSENSITIVITY |
|
|
Term
ADRENERGIC-BLOCKER THERAPY
PROTOTYPE |
|
Definition
|
|
Term
ADRENERGIC-BLOCKER THERAPY
PROTOTYPE: PRAZOSIN
THERAPUETIC |
|
Definition
|
|
Term
ADRENERGIC-BLOCKER THERAPY
PROTOTYPE: PRAZOSIN
THERAPUETIC EFFECTS |
|
Definition
BPH, NARROW-ANGLE GLAUCOMA
HYPERTENSION
ANGINA PECTORIS
MIGRAINES
HEART FAILURE |
|
|
Term
ADRENERGIC-BLOCKER THERAPY
PROTOTYPE: PRAZOSIN
ADVERSE EFFECTS |
|
Definition
DECREASED LOC
FATIGUE
DRY MOUTH
ORTHOSTATIC HYPOTENSION |
|
|
Term
ADRENERGIC-BLOCKER THERAPY
PROTOTYPE: PRAZOSIN
ACTION/USES |
|
Definition
RAPID DECREASE IN PERIPHERAL RESISTANCE THAT REDUCES BP
COMMONLY USED WITH BETA BLOCKERS OR DIURETICS
BLOCKS ALPHA-BETA RECEPTORS OF THE SNS |
|
|
Term
ADRENERGIC-BLOCKER THERAPY
PROTOTYPE: PRAZOSIN
ADMIN ALERTS |
|
Definition
| LOW DOSE TO AVOID SEVERE HYPOTENSION |
|
|
Term
ADRENERGIC-BLOCKER THERAPY
PROTOTYPE: PRAZOSIN
INTERACTION |
|
Definition
| AVOID ALCOHOL, SAW PALMETTO (DILATES VESSELS AND A HYPOTENSIVE RESPONSE) OR NETTLE ROOT PRODUCTS |
|
|
Term
ADRENERGIC (SYMPATHOMIMETIC) THERAPY
PROTOTYPE |
|
Definition
|
|
Term
ADRENERGIC (SYMPATHOMIMETIC) THERAPY
PROTOTYPE: PHENULEPHRINE
THERAPUETIC CLASS |
|
Definition
NASAL DECONGESTANT
MYDRATIC AGENT
ANTIHYPERTENSIVE
|
|
|
Term
ADRENERGIC (SYMPATHOMIMETIC) THERAPY
PROTOTYPE
THERAPUETIC EFFECT |
|
Definition
PANCREATITIS
HEPATITIS
WEIGHT LOSS
ASTHMA
WIDE-ANGLE GLAUCOMA |
|
|
Term
ADRENERGIC (SYMPATHOMIMETIC) THERAPY
PROTOTYPE: PHENYLEPHRINE
CONTRAINDICATIONS |
|
Definition
HYPERTHYROIDISM- SEVERE INCREASE IN BASAL METABOLIC RATE, RESULTING IN INCREASED BP AND VENTRICAL TACHYCARDIA
I |
|
|
Term
ADRENERGIC (SYMPATHOMIMETIC) THERAPY
PROTOTYPE: PHENYLEPHRINE
INTERACTIONS |
|
Definition
DYSRYTHMIAS-DIGOXIN
MAOI- HYPERTENSIVE CRISIS |
|
|
Term
ADRENERGIC (SYMPATHOMIMETIC) THERAPY
PROTOTYPE: PHENYLEPHRINE
STIMULATES SNS? |
|
Definition
|
|
Term
ADRENERGIC (SYMPATHOMIMETIC) THERAPY
PROTOTYPE: PHENYLEPHRINE
OVERDOSE/ANIDOTE |
|
Definition
| APLHA-BLOCKER (PHENTOLAMINE)(REGITINE) |
|
|
Term
ADRENERGIC (SYMPATHOMIMETIC) THERAPY
PROTOTYPE: PHENYLEPHRINE
INSPECT AFTER NASAL USE FOR? |
|
Definition
EPITAXIS: NASAL BLEEDING
REBOUND CONGESTION |
|
|
Term
ADRENERGIC (SYMPATHOMIMETIC) THERAPY
PROTOTYPE: PHENYLEPHRINE
HIGH DOSE CAN CAUSE? |
|
Definition
| REFLEX BRADYCARDIA: PALPATIONS, SOB, CHEST PAIN, EXCESSIVE NERVOUSNESS OR TREMORS |
|
|
Term
ANTIDEPRESSANT THERAPY
PROTOTYPE |
|
Definition
|
|
Term
ANTIDEPRESSANT THERAPY
PROTOTYPE: PHENELZINE
THERAPUETIC CLASS |
|
Definition
|
|
Term
ANTIDEPRESSANT THERAPY
PROTOTYPE: PHENELZINE
PHARMACOLOGIC CLASS |
|
Definition
|
|
Term
ANTIDEPRESSANT THERAPY
PROTOTYPE: PHENELZINE
CONTRAINDICATIONS |
|
Definition
CARDIOVASCULAR DISEASE
HEART FAILURE
CVA
PARANOID SCHIZOPHRENIA |
|
|
Term
ANTIDEPRESSANT THERAPY
PROTOTYPE: PHENELZINE
ACTION/USES |
|
Definition
INTENSIFIES EFFECTS OF NE IN ADRENERGIC SYNAPSES
TREAT DEPRESSION, PANIC DISORDERS |
|
|
Term
ANTIDEPRESSANT THERAPY
PROTOTYPE: PHENELZINE
ADMIN ALERTS |
|
Definition
2-3 WKS BEFORE INTRODUCING ANOTHER DRUG
ABRUPT DISCONTINUATION MAY CAUSE REBOUND HYPERTENSION |
|
|
Term
ANTIDEPRESSANT THERAPY
PROTOTYPE: PHENELZINE
ADVERSE EFFECTS |
|
Definition
ORTHOSTATIC HYPERTENSION
HEADACHE
INSOMNIA
DIARRHEA |
|
|
Term
ANTIDEPRESSANT THERAPY
PROTOTYPE: PHENELZINE
INTERACTIONS |
|
Definition
GINSENG MAY CAUSE HEADACHES, TREMORS, MANIA, INSOMNIA, IRRITABILITY, VISUAL HALLUCINATIONS
MU HUANG, EPHEDRA OR ST.JOHN'S WORT MAY RESULT IN HYPERTENSION CRISIS |
|
|
Term
ANTIDEPRESSANT THERAPY
PROTOTYPE: PHENELZINE
OVERDOSE/ANTIDOTE |
|
Definition
EMESIS OR GASTRIC LAVAGE W/ INSTILLATION OF CHARCOAL SLURRY
CNS STIMULATION(SEIZURES)--> IV VALIUM
HYPERTENSION--> CALCIUM CHANNEL BLOCKERS
HYPOTENSION AND VASCULAR COLLAPSE--> IV FLUIDS
BODY TEMP MONITORED AND RESPIRATION SUPPORTED W/ APPROPRIATE MEASURES |
|
|
Term
|
Definition
|
|
Term
NSAID THERAPY
PROTOTYPE: ASPIRIN
THERAPUETIC CLASS |
|
Definition
|
|
Term
NSAID THERAPY
PROTOTYPE: ASPIRIN
PHARMALOGIC CLASS |
|
Definition
| SALICYLATE, COX INHIBITOR |
|
|
Term
NSAID THERAPY
PROTOTYPE: ASPIRIN
CONTRADICTIONS |
|
Definition
| SHOULD NOT BE GIVEN TO PATIENTS RECIEVING ANTICOUAGULENT THERAPY, SUCH AS WARFRIN, HEPARIN, AND PLICAMYIN |
|
|
Term
NSAID THERAPY
PROTOTYPE: ASPIRIN
ACTION/USES |
|
Definition
MILD/MODERATE RELIEF OF FEVER
LIMITED EFFECT ON PERIPHERAL BLOOD VESSELS--> VASODILATION/SWEATING
ANTICOAGULENT
REDUCE RISK ON COLORECTAL CANCER
|
|
|
Term
NSAID THERAPY
PROTOTYPE: ASPIRIN
ADMIN ALERTS |
|
Definition
PLATLETE AGGREGATION INHIBITION IS IRREVERSIBLE
DISCONTINUE 1 WK PRIOR TO ELECTIVE SURGERY
EXCRETED IN URINE AND AFFECTS URINE TESTING FOR GLUCOSE AND METABOLITES |
|
|
Term
NSAID THERAPY
PROTOTYPE: ASPIRIN
ADVERSE EFFECTS |
|
Definition
GASTRIC DISCOMFORT
BLEEDING B/C OF ANITPLATLETE
HEARIG LOSS
ENTERIC-COATED TABLETS |
|
|
Term
NSAID THERAPY
PROTOTYPE: ASPIRIN
OVERDOSE/ANTIDOTE |
|
Definition
ACTIVATED CHARCOAL, GASTRIC LAVAGE, LAXATIVE
SYMPTOMS: DIZZINESS, DROWSINESS, ABDOMINAL PAIN, SEIZURES |
|
|
Term
NSAID THERAPY
PROTOTYPE: ASPIRIN
INTERACTIONS |
|
Definition
| FEVER, GARLIC, GINGER, AND GINKO MAY INCREASE THE RISK OF BLEEDING |
|
|
Term
NSAID THERAPY
PROTOTYPE: ASPIRIN
HOW SHOULD THEY BE TAKEN? |
|
Definition
| WITH FOOD OR MILK TO DECREASE GI UPSET |
|
|
Term
|
Definition
|
|
Term
OPIOID THERAPY
PROTOTYPE: MORPHINE/NALOXNE(NARCAN)
PHARMALOCICAL CLASS |
|
Definition
MORPHINE: OPIOID RECEPTOR AGONIST
NALOXNE: OPIOID RECEPTOR ANTAGONIST |
|
|
Term
OPIOID THERAPY
PROTOTYPE: MORPHINE/NALOXNE(NARCAN)
THERAPUETIC CLASS |
|
Definition
|
|
Term
OPIOID THERAPY
PROTOTYPE: MORPHINE/NALOXNE(NARCAN)
THERAPUETIC EFFECT |
|
Definition
|
|
Term
OPIOID THERAPY
PROTOTYPE: MORPHINE/NALOXNE(NARCAN)
CONTRAINDICATIONS |
|
Definition
MAY MASK PAIN OF GALLBLADDER DISEASE
AVOID IN ASTHMA, HEPATIC OR RENAL IMPAIRMENT |
|
|
Term
OPIOID THERAPY
PROTOTYPE: MORPHINE/NALOXNE(NARCAN)
ACTION/USES |
|
Definition
| CAUSES EUPHORIA, CONSTRICTION OF PUPILS, STIMULATION OF CARDIAC MUSCLE |
|
|
Term
OPIOID THERAPY
PROTOTYPE: MORPHINE/NALOXNE(NARCAN)
ADMIN ALERTS |
|
Definition
ORAL SOLUTION MAY BE GIVEN SUBLINGUALLY
ORAL SOLUTIONS COME IN MULTIPLE STRENGTHS, CAREFULLY OBSERVE DRUG ORDERS/LABELS
MORPHINE CAUSES PERIPHERAL VASODILATION, RESULTS IN ORTHOSTATIC HYPERTENSION |
|
|
Term
OPIOID THERAPY
PROTOTYPE: MORPHINE/NALOXNE(NARCAN)
ADVERSE EFFECTS |
|
Definition
(MORPHINE) DYSPHORIA--RESTLESS, DEPRESSION, ANXIETY
HALLUCINATIONS, NAUSEA, CONSTIPATION, DIZZINESS, ITCHING SENSATION, VOMITING, SEDATION,
SEVERE RESPIRATORY DEPRESSION OR CARDIAC ARREST
TOLERANCE DEVELOPS TO THE SEDATIVE/EUPHIC EFFECT
CROSS-TOLERANCE= HEROINE |
|
|
Term
OPIOID THERAPY
PROTOTYPE: MORPHINE/NALOXNE(NARCAN)
INTERACTIONS |
|
Definition
| YOHIMBA, KARAKARA, VALERIAN, ST.JOHN'S WORT--> POTENTIATES EFFECT OF MORPHINE |
|
|
Term
OPIOID THERAPY
PROTOTYPE: MORPHINE/NALOXNE(NARCAN)
OVERDOSE/ANTIDOTE |
|
Definition
IV ADMINISTRATION OF NALOXONE(NARCAN)
ACTIVATED CHARCOAL, LAXATIVE, COUNTERACTING NARCOTIC ANTAGONIST |
|
|
Term
TRIPTAN THERAPY
PROTOTYPE |
|
Definition
|
|
Term
TRIPTAN THERAPY
PROTOTYPE: TRIPTAN
THERAPUETIC CLASS |
|
Definition
|
|
Term
TRIPTAN THERAPY
PROTOTYPE: TRIPTAN (SUMATRIPAN)
PHARMALOGICAL CLASS |
|
Definition
| SEROTONIN RECEPTOR AGENT, VASOCONSTRICTION OF INTERCRANIAL ARTERIES |
|
|
Term
TRIPTAN THERAPY
PROTOTYPE: TRIPTAN (SUMATRIPAN)
CONTRAINDICATIONS |
|
Definition
| ALL PATIENTS WITH RECENT MI, OR WITH A HISTORY OF ANGINA PECTORIS, HYPERTENSION, OR DIABETES |
|
|
Term
TRIPTAN THERAPY
PROTOTYPE: TRIPTAN (SUMATRIPAN)
ACTION/USES |
|
Definition
VASOCONSTRICTION OF CRANIAL ARTERIES(DOES NOT USUALLY AFFECT OVERALL BP
AVAILABLE IN ORAL, INERNASAL, SUBCUTANEOUS
SUBCUTANEOUS TERMINATES MIGRAINE ATTACKS W/IN 10-20 MIN--> MAY BE REPEATED AFTER 60MIN
|
|
|
Term
TRIPTAN THERAPY
PROTOTYPE: TRIPTAN (SUMATRIPAN)
ADMIN ALERTS |
|
Definition
PRODUCE CARDIAC ISCHEMIA
SYSTEMIC VASOCONSTRICTOR ACTIVITY MAY CAUSE HYPERTENSION AND MAY RESULT IN DYSRHYTHMIAS OR MI
REDUCES CAROTID ARTERIAL BLOOD FLOW-->MONITOR CHANGES IN LOC AND OBSERVE FOR SEIZURES |
|
|
Term
TRIPTAN THERAPY
PROTOTYPE: TRIPTAN (SUMATRIPAN)
ADVERSE EFFECT |
|
Definition
DIZZINESS, DROWSINESS, WARM SENSATION
VASOCONSTRICTION |
|
|
Term
TRIPTAN THERAPY
PROTOTYPE: TRIPTAN (SUMATRIPAN)
OVERDOSE/ANTIDOTE |
|
Definition
| TREATMENT MAY INCLUDE DRUG THERAPY FOR: WEAKNESS, LACK OF COORDINATION, WATERY EYES AND MOUTH, TREMORS, SEIZURES, BREATHING PROBLEMS |
|
|
Term
BENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE |
|
Definition
|
|
Term
BENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: LORAZEPAM (ATIVAN)
THERAPUETIC CLASS
|
|
Definition
| SEDATIVE-HYPNOTIC, ANXIOLYTIC, ANESTHETIC ADJUNCT |
|
|
Term
BENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: LORAZEPAM (ATIVAN)
PHARMALOGICAL CLASS |
|
Definition
| BENZODIAZEPINE, GABAa-RECEPTOR AGONIST |
|
|
Term
BENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: LORAZEPAM (ATIVAN)
THERAPUETIC EFFECT |
|
Definition
ANXIETY DISORDERS
INSOMNIA |
|
|
Term
BENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: LORAZEPAM (ATIVAN)
ACTION/USES |
|
Definition
POTENTIATING EFFECTS OF GABA IN THE THALAMIC, HYPOTHALAMIC, AND LIMBIC LEVELS OF CNS
PREANESTHETIC MEDICATION TO PROVIDE SEDATION, AND MANAGEMENT OF STATUS EPILEPTICUS |
|
|
Term
BENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: LORAZEPAM (ATIVAN)
ADMIN ALERTS |
|
Definition
(IV)-MONITOR RESPIRATION EVERY 5-15 MIN
HAVE AIRWAY AND RESUSCITATIVE EQUIPMENT ACCESSIBLE |
|
|
Term
BENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: LORAZEPAM (ATIVAN)
CONTRAINDICATIONS |
|
Definition
PRIMARY DEPRESSIVE DISORDERS, PSYCHOSIS
SHOULD BE AVOIDED FOR THE MANAGEMENT OF SEVERE UNCONTROLLED PAIN |
|
|
Term
BENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: LORAZEPAM (ATIVAN)
INTERACTIONS |
|
Definition
KAVA, VALERIAN, CHAMOMILE OR HOPS MAY HAVE AN ADDITIVE EFFECT W/ MEDS
GOTU KOLA AND MA HUANG MAY REDUCE THE DRUGS EFFECTIVENESS |
|
|
Term
BENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: LORAZEPAM (ATIVAN)
OVERDOSE/ANTIDOTE |
|
Definition
| FLUMAZENIL(RAMAZICON)-->REVERSE CNS DEPRESSANT EFFECT |
|
|
Term
NONBENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE |
|
Definition
|
|
Term
NONBENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: ZOLPIDEM(AMBIEN)
THERAPUETIC CLASS |
|
Definition
|
|
Term
NONBENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: ZOLPIDEM(AMBIEN)
PHARMALOGICAL CLASS |
|
Definition
| NONBENZODIAZEPHINE GABAa RECEPTOR AGONISTN NONBARBITURATE CNS DEPRESSANTS |
|
|
Term
NONBENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: ZOLPIDEM(AMBIEN)
ACTION/USES |
|
Definition
| PRESERVES STAGES III AND IV OF SLEEP, SHORT TERM INSOMNIA MANAGEMENT (7-10 DAYS) |
|
|
Term
NONBENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: ZOLPIDEM(AMBIEN)
ADMIN ALERTS |
|
Definition
| RAPID ONSET (7-27 MIN) BEFORE BEDTIME |
|
|
Term
NONBENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: ZOLPIDEM(AMBIEN)
CONTRAINDICATIONS |
|
Definition
| LACTATING WOMEN SHOULD NOT TAKE THIS DRUG |
|
|
Term
NONBENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: ZOLPIDEM(AMBIEN)
ADVERSE EFFECT |
|
Definition
|
|
Term
NONBENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: ZOLPIDEM(AMBIEN)
INTERACTIONS |
|
Definition
| ABSORPTION IS SLOWED WHEN TAKEN WITH FOODS |
|
|
Term
NONBENZODIAZEPHINE ANTIANXIETY THERAPY
PROTOTYPE: ZOLPIDEM(AMBIEN)
OVERDOSE/ANTIDOTE |
|
Definition
FLUMAZENIL (ROMAZICON)
IMMEDIATES GASTRIC LAVAGE WHERE APPROPRIATE
IV FLUIDS WHEN NEEDED |
|
|
